Selective, Orally Active 5-HT_1D Receptor Agonists as Potential Antimigraine Agents

This publication has 7 references indexed in Scilit:

• Inhibition of the Trigemino-Vascular System with 5-HT1D Agonist Drugs: Selectively Targeting Additional Sites of Action
  European Neurology, 1996
• The activity of 5-HT1D receptor ligands at cloned human 5-HT1Dα and 5-HT1Dβ receptors
  European Journal of Pharmacology, 1995
• A comparison of the contractile effects of 5‐hydroxytryptamine, sumatriptan and MK‐462 on human coronary artery in vitro.
  British Journal of Clinical Pharmacology, 1995
• Neurogenic Model of Migraine
  Cephalalgia, 1995
• Classification and nomenclature of somatostatin receptors
  Trends in Pharmacological Sciences, 1995
• Adverse reactions attributed to sumatriptan
  European Journal of Clinical Pharmacology, 1994
• Cloning of another human serotonin receptor (5-HT1F): a fifth 5-HT1 receptor subtype coupled to the inhibition of adenylate cyclase.
  Proceedings of the National Academy of Sciences, 1993